HER-2 阴性乳腺癌的临床试验
总计12021个结果
-
Dompé Farmaceutici S.p.APRA Health Sciences完全的
-
German Breast GroupAstraZeneca完全的乳腺癌 | 三阴性乳腺肿瘤 | HRpos 乳腺肿瘤 | BRCA 1 /2 和/或 HRD德国
-
Case Comprehensive Cancer Center撤销I期乳腺癌 | HER2阳性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | 雌激素受体阴性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阴性乳腺癌 | 孕激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 乳腺导管原位癌 | 浸润性小叶乳腺癌 | 浸润性导管癌 | 伴有淋巴细胞浸润的髓样导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌美国
-
University of WashingtonUnited States Department of Defense; Breast Cancer Alliance主动,不招人IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | III期乳腺癌 | HER2 阴性乳腺癌美国
-
Prescient Therapeutics, Ltd.National Cancer Institute (NCI)终止IV 期乳腺癌 | 复发性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 乳腺癌美国
-
ConcrRoyal Marsden NHS Foundation Trust; Institute of Cancer Research, United Kingdom; Durham University邀请报名
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Novartis Pharmaceuticals完全的HR+/HER2- 晚期或转移性乳腺癌爱尔兰
-
University of WashingtonNational Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 男性乳腺癌美国
-
National Cancer Institute (NCI)撤销雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | IV 期乳腺癌 AJCC v6 和 v7
-
City of Hope Medical CenterNational Cancer Institute (NCI); Imugene Limited主动,不招人
-
Kathy MillerGenentech, Inc.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.尚未招聘HR+/HER2- 晚期和/或转移性乳腺癌
-
AstraZeneca完全的Postmenopausal Women With ER+ HER2- Primary Breast Cancer德国, 英国
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)招聘中IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | 雌激素受体和/或孕激素受体阳性美国
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance Hospital招聘中乳腺癌 | 手术 | 复发性乳腺癌 | 雌激素受体阳性肿瘤 | 立体定向放疗 | Her2-negative Tumor大韩民国
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
The Netherlands Cancer InstituteHoffmann-La Roche尚未招聘
-
National Taiwan University HospitalDebiopharm International SA; Ministry of Health and Welfare尚未招聘三阴性乳腺癌 | 绝经前乳腺癌
-
University of Milano BicoccaEISAI s.r.l.招聘中
-
Henrik DitzelNational Board of Health, Denmark; CytoVac A/S招聘中
-
Massachusetts General HospitalMerck Sharp & Dohme LLC主动,不招人
-
SanofiSOLTI Breast Cancer Research Group完全的
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Roswell Park Cancer Institute尚未招聘解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 局部晚期不可切除的三阴性乳腺癌美国
-
National Cancer Institute (NCI)暂停解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 不可切除的三阴性乳腺癌美国
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的
-
Fudan University未知
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)主动,不招人解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
Dana-Farber Cancer InstituteGenentech, Inc.招聘中乳腺癌 | HER2阳性乳腺癌 | 激素受体阳性乳腺癌 | 浸润性乳腺癌 | 淋巴结阴性乳腺癌 | 微转移乳腺癌美国